SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-056514
Filing Date
2022-05-05
Accepted
2022-05-05 16:47:28
Documents
6
Effectiveness Date
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2214557d1_s8.htm S-8 55353
2 EXHIBIT 5.1 tm2214557d1_ex5-1.htm EX-5.1 10686
3 EXHIBIT 23.1 tm2214557d1_ex23-1.htm EX-23.1 2413
4 EX-FILING FEES tm2214557d1_ex-filingfees.htm EX-FILING FEES 19786
5 GRAPHIC tm2214557d1_ex5-1img001.jpg GRAPHIC 2325
6 GRAPHIC tm2214557d1_ex5-1img002.jpg GRAPHIC 1765
  Complete submission text file 0001104659-22-056514.txt   95220
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264718 | Film No.: 22897237
SIC: 2834 Pharmaceutical Preparations